Exact Mass: 490.2333324

Glimepiride

C24H34N4O5S (490.22497940000005)

Glimepiride is only found in individuals that have used or taken this drug. It is the first III generation sulphonyl urea it is a very potent sulphonyl urea with long duration of action.The mechanism of action of glimepiride in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glimepiride likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D007004 - Hypoglycemic Agents

Rubraflavone C

C30H34O6 (490.2355264)

Rubraflavone C is found in fruits. Rubraflavone C is a constituent of Morus rubra (red mulberry)

Niludipine

C25H34N2O8 (490.2315044)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Bis(2-propoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate

C25H34N2O8 (490.2315044)

PA(2:0/18:2(10E,12Z)+=O(9))

C23H39O9P (490.23315740000004)

PA(2:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(10E,12Z)+=O(9)/2:0)

C23H39O9P (490.23315740000004)

PA(18:2(10E,12Z)+=O(9)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/2:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/18:2(9Z,11E)+=O(13))

C23H39O9P (490.23315740000004)

PA(2:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(9Z,11E)+=O(13)/2:0)

C23H39O9P (490.23315740000004)

PA(18:2(9Z,11E)+=O(13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/2:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/18:3(10,12,15)-OH(9))

C23H39O9P (490.23315740000004)

PA(2:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(10,12,15)-OH(9)/2:0)

C23H39O9P (490.23315740000004)

PA(18:3(10,12,15)-OH(9)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/2:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/18:3(9,11,15)-OH(13))

C23H39O9P (490.23315740000004)

PA(2:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(9,11,15)-OH(13)/2:0)

C23H39O9P (490.23315740000004)

PA(18:3(9,11,15)-OH(13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/2:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Tanariflavanone B

C30H34O6 (490.2355264)

A trihydroxyflavanone that consists of (2S)-2,3-dihydro-2H,4H-2,5-bichromen-4-one skeleton substituted by hydroxy groups at positions 5, 7 and 8, a methyl group at position 2, a prenyl group at position 6 and a 4-methylpent-3-enyl group at position 2. Isolated from Macaranga tanarius, it exhibits alleopathic effect.

euchrenone a6

C30H34O6 (490.2355264)

Lindenanolide F

C30H34O6 (490.2355264)

Amoridin

C30H34O6 (490.2355264)

Murrastifoline D

C32H30N2O3 (490.225631)

Decathieleanolide

C30H34O6 (490.2355264)

Millewanin C

C30H34O6 (490.2355264)

Terrequinone A

C32H30N2O3 (490.225631)

A bisindole alkaloid that is quinone bearing a hydroxy substituent at position 2, a 3,3-dimethylallyl group at position 5 and two indol-3-yl groups at positions 3 and 6, one of which is carrying a 1,1-dimethylallyl group at position 2.

Macaflavanone B

C30H34O6 (490.2355264)

Amorinin

C30H34O6 (490.2355264)

Sanggenol B

C30H34O6 (490.2355264)

dorsilurin E

C30H34O6 (490.2355264)

Macaflavanone C

C30H34O6 (490.2355264)

macaflavanone E

C30H34O6 (490.2355264)

Moralbanone

C30H34O6 (490.2355264)

Artocommunol CD

C30H34O6 (490.2355264)

Artelasticin

C30H34O6 (490.2355264)

Dorsilurin A

C30H34O6 (490.2355264)

Macaflavanone D

C30H34O6 (490.2355264)

Euchrenone b2

C30H34O6 (490.2355264)

Rubraflavone C

C30H34O6 (490.2355264)

Flemichin C

C30H34O6 (490.2355264)

DORSILURIN F

C30H34O6 (490.2355264)

A 7-hydroxyflavonol substituted by additional hydroxy groups at positions 5 and 3 and prenyl groups at positions 6, 8 and 4. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity. D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D004791 - Enzyme Inhibitors

DORSILURIN K

C30H34O6 (490.2355264)

An extended flavonoid that is flavonol with an additional hydroxy group at position 3, two 2,2-dimethyldihydropyrano rings fused to ring A across positions 5, 6 and 7, 8 respectively and a prenyl group at position 4. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity.

(+)-angelicoidenol 2-O-[6-O-S-3-hydroxy-3-methylglutaryl]-beta-D-glucopyranoside|zingiberoside C methyl ester

C23H38O11 (490.24139979999995)

C30H34O6

C30H34O6 (490.2355264)

DORSILURIN J

C30H34O6 (490.2355264)

An extended flavonoid that is 7-hydroxyflavonol with an additional hydroxy group at position 3, a 2,2-dimethyldihydropyrano ring fused to ring A across positions 5 and 6, and prenyl groups at positions 8 and 4. Isolated from the roots of Dorstenia psilurus, it exhibits alpha-glucosidase inhibitory activity.

1-[5,7-dihydroxy-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)chromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one

C30H34O6 (490.2355264)

(+)-7,7-bis[(5R,7R,9R,10S)-2-oxocadinan-3,6(11)-dien-12,7-olide]

C30H34O6 (490.2355264)

5,7,2,4-tetrahydroxy-3-geranyl-8-prenylflavone|artocommunol CD

C30H34O6 (490.2355264)

(2S)-5,2,4-trihydroxy-8,5-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone

C30H34O6 (490.2355264)

psiguadials C

C30H34O6 (490.2355264)

klymollin L

C24H39ClO8 (490.2333324)

3-(3,4-dihydroxyphenyl)-1-[6-(3,7-dimethylocta-2,6-dienyl)-5,7-dihydroxy-2,2-dimethylchromen-8-yl]prop-2-en-1-one

C30H34O6 (490.2355264)

8-(3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one|moralbanone

C30H34O6 (490.2355264)

mesuagenin D

C30H34O6 (490.2355264)

kadcoccilactone L

C30H34O6 (490.2355264)

(S)-Isoamoridin

C30H34O6 (490.2355264)

5,7,3-trihydroxy-4,5-(2,2-dimethylpyran)-8,2-di(3-methyl-2-butenyl)-(2S)-flavanone

C30H34O6 (490.2355264)

An extended flavonoid that consists of (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 3, prenyl groups at positions 8 and 2 and a gem-dimethyl pyran ring fused across positions 4 and 5. Isolated from Dendrolobium lanceolatum, it exhibits antimalarial activity.

Thr Asp Gln Lys

C19H34N6O9 (490.23871540000005)

Ser Glu Gln Lys

C19H34N6O9 (490.23871540000005)

Ala Ala Lys Ser Asp

C19H34N6O9 (490.23871540000005)

Lys Gln Ser Glu

C19H34N6O9 (490.23871540000005)

Asp Gln Thr Lys

C19H34N6O9 (490.23871540000005)

Thr Asn Lys Glu

C19H34N6O9 (490.23871540000005)

Thr Lys Asn Glu

C19H34N6O9 (490.23871540000005)

Thr Leu Asp Glu

C20H34N4O10 (490.2274824)

Asn Thr Glu Lys

C19H34N6O9 (490.23871540000005)

3-Geranyl-3-prenyl-5,7,2,4-tetrahydroxyflavone

C30H34O6 (490.2355264)

glimepiride

C24H34N4O5S (490.22497940000005)

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 2355 CONFIDENCE standard compound; INTERNAL_ID 8512

Ala Met Asn Arg

C18H34N8O6S (490.23219040000004)

Ala Met Arg Asn

C18H34N8O6S (490.23219040000004)

Ala Asn Met Arg

C18H34N8O6S (490.23219040000004)

Ala Asn Arg Met

C18H34N8O6S (490.23219040000004)

Ala Arg Met Asn

C18H34N8O6S (490.23219040000004)

Ala Arg Asn Met

C18H34N8O6S (490.23219040000004)

Cys Gly Arg Arg

C17H34N10O5S (490.24342340000004)

Cys Asn Arg Val

C18H34N8O6S (490.23219040000004)

Cys Asn Val Arg

C18H34N8O6S (490.23219040000004)

Cys Arg Gly Arg

C17H34N10O5S (490.24342340000004)

Cys Arg Asn Val

C18H34N8O6S (490.23219040000004)

Cys Arg Arg Gly

C17H34N10O5S (490.24342340000004)

Cys Arg Val Asn

C18H34N8O6S (490.23219040000004)

Cys Val Asn Arg

C18H34N8O6S (490.23219040000004)

Cys Val Arg Asn

C18H34N8O6S (490.23219040000004)

Asp Phe Ile Pro

C24H34N4O7 (490.2427374)

Asp Phe Leu Pro

C24H34N4O7 (490.2427374)

Asp Phe Pro Ile

C24H34N4O7 (490.2427374)

Asp Phe Pro Leu

C24H34N4O7 (490.2427374)

Asp Ile Phe Pro

C24H34N4O7 (490.2427374)

Asp Ile Pro Phe

C24H34N4O7 (490.2427374)

Asp Lys Gln Thr

C19H34N6O9 (490.23871540000005)

Asp Lys Thr Gln

C19H34N6O9 (490.23871540000005)

Asp Leu Phe Pro

C24H34N4O7 (490.2427374)

Asp Leu Pro Phe

C24H34N4O7 (490.2427374)

Asp Pro Phe Ile

C24H34N4O7 (490.2427374)

Asp Pro Phe Leu

C24H34N4O7 (490.2427374)

Asp Pro Ile Phe

C24H34N4O7 (490.2427374)

Asp Pro Leu Phe

C24H34N4O7 (490.2427374)

Asp Gln Lys Thr

C19H34N6O9 (490.23871540000005)

Asp Thr Lys Gln

C19H34N6O9 (490.23871540000005)

Asp Thr Gln Lys

C19H34N6O9 (490.23871540000005)

Glu Glu Ile Thr

C20H34N4O10 (490.2274824)

Glu Glu Leu Thr

C20H34N4O10 (490.2274824)

Glu Glu Thr Ile

C20H34N4O10 (490.2274824)

Glu Glu Thr Leu

C20H34N4O10 (490.2274824)

Glu Phe Pro Val

C24H34N4O7 (490.2427374)

Glu Phe Val Pro

C24H34N4O7 (490.2427374)

Glu Ile Glu Thr

C20H34N4O10 (490.2274824)

Glu Ile Thr Glu

C20H34N4O10 (490.2274824)

Glu Lys Asn Thr

C19H34N6O9 (490.23871540000005)

Glu Lys Gln Ser

C19H34N6O9 (490.23871540000005)

Glu Lys Ser Gln

C19H34N6O9 (490.23871540000005)

Glu Lys Thr Asn

C19H34N6O9 (490.23871540000005)

Glu Leu Glu Thr

C20H34N4O10 (490.2274824)

Glu Leu Thr Glu

C20H34N4O10 (490.2274824)

Glu Asn Lys Thr

C19H34N6O9 (490.23871540000005)

Glu Asn Thr Lys

C19H34N6O9 (490.23871540000005)

Glu Pro Phe Val

C24H34N4O7 (490.2427374)

Glu Pro Val Phe

C24H34N4O7 (490.2427374)

Glu Gln Lys Ser

C19H34N6O9 (490.23871540000005)

Glu Gln Ser Lys

C19H34N6O9 (490.23871540000005)

Glu Ser Lys Gln

C19H34N6O9 (490.23871540000005)

Glu Ser Gln Lys

C19H34N6O9 (490.23871540000005)

Glu Thr Glu Ile

C20H34N4O10 (490.2274824)

Glu Thr Glu Leu

C20H34N4O10 (490.2274824)

Glu Thr Ile Glu

C20H34N4O10 (490.2274824)

Glu Thr Lys Asn

C19H34N6O9 (490.23871540000005)

Glu Thr Leu Glu

C20H34N4O10 (490.2274824)

Glu Thr Asn Lys

C19H34N6O9 (490.23871540000005)

Glu Val Phe Pro

C24H34N4O7 (490.2427374)

Glu Val Pro Phe

C24H34N4O7 (490.2427374)

Phe Asp Ile Pro

C24H34N4O7 (490.2427374)

Phe Asp Leu Pro

C24H34N4O7 (490.2427374)

Phe Asp Pro Ile

C24H34N4O7 (490.2427374)

Phe Asp Pro Leu

C24H34N4O7 (490.2427374)

Phe Glu Pro Val

C24H34N4O7 (490.2427374)

Phe Glu Val Pro

C24H34N4O7 (490.2427374)

Phe Ile Asp Pro

C24H34N4O7 (490.2427374)

Phe Ile Pro Asp

C24H34N4O7 (490.2427374)

Phe Leu Asp Pro

C24H34N4O7 (490.2427374)

Phe Leu Pro Asp

C24H34N4O7 (490.2427374)

Phe Met Pro Pro

C24H34N4O5S (490.22497940000005)

Phe Pro Asp Ile

C24H34N4O7 (490.2427374)

Phe Pro Asp Leu

C24H34N4O7 (490.2427374)

Phe Pro Glu Val

C24H34N4O7 (490.2427374)

Phe Pro Ile Asp

C24H34N4O7 (490.2427374)

Phe Pro Leu Asp

C24H34N4O7 (490.2427374)

Phe Pro Met Pro

C24H34N4O5S (490.22497940000005)

Phe Pro Pro Met

C24H34N4O5S (490.22497940000005)

Phe Pro Val Glu

C24H34N4O7 (490.2427374)

Phe Val Glu Pro

C24H34N4O7 (490.2427374)

Phe Val Pro Glu

C24H34N4O7 (490.2427374)

Gly Cys Arg Arg

C17H34N10O5S (490.24342340000004)

Gly Met Gln Arg

C18H34N8O6S (490.23219040000004)

Gly Met Arg Gln

C18H34N8O6S (490.23219040000004)

Gly Gln Met Arg

C18H34N8O6S (490.23219040000004)

Gly Gln Arg Met

C18H34N8O6S (490.23219040000004)

Gly Arg Cys Arg

C17H34N10O5S (490.24342340000004)

Gly Arg Met Gln

C18H34N8O6S (490.23219040000004)

Gly Arg Gln Met

C18H34N8O6S (490.23219040000004)

Gly Arg Arg Cys

C17H34N10O5S (490.24342340000004)

His His Pro Thr

C21H30N8O6 (490.22882)

His His Thr Pro

C21H30N8O6 (490.22882)

His Pro His Thr

C21H30N8O6 (490.22882)

His Pro Thr His

C21H30N8O6 (490.22882)

His Thr His Pro

C21H30N8O6 (490.22882)

His Thr Pro His

C21H30N8O6 (490.22882)

Ile Asp Phe Pro

C24H34N4O7 (490.2427374)

Ile Asp Pro Phe

C24H34N4O7 (490.2427374)

Ile Glu Glu Thr

C20H34N4O10 (490.2274824)

Ile Glu Thr Glu

C20H34N4O10 (490.2274824)

Ile Phe Asp Pro

C24H34N4O7 (490.2427374)

Ile Phe Pro Asp

C24H34N4O7 (490.2427374)

Ile Met Met Pro

C21H38N4O5S2 (490.2283498)

Ile Met Pro Met

C21H38N4O5S2 (490.2283498)

Ile Pro Asp Phe

C24H34N4O7 (490.2427374)

Ile Pro Phe Asp

C24H34N4O7 (490.2427374)

Ile Pro Met Met

C21H38N4O5S2 (490.2283498)

Ile Thr Glu Glu

C20H34N4O10 (490.2274824)

Lys Asp Gln Thr

C19H34N6O9 (490.23871540000005)

Lys Asp Thr Gln

C19H34N6O9 (490.23871540000005)

Lys Glu Asn Thr

C19H34N6O9 (490.23871540000005)

Lys Glu Gln Ser

C19H34N6O9 (490.23871540000005)

Lys Glu Ser Gln

C19H34N6O9 (490.23871540000005)

Lys Glu Thr Asn

C19H34N6O9 (490.23871540000005)

Lys Asn Glu Thr

C19H34N6O9 (490.23871540000005)

Lys Asn Thr Glu

C19H34N6O9 (490.23871540000005)

Lys Gln Asp Thr

C19H34N6O9 (490.23871540000005)

Lys Gln Glu Ser

C19H34N6O9 (490.23871540000005)

Lys Gln Thr Asp

C19H34N6O9 (490.23871540000005)

Lys Ser Glu Gln

C19H34N6O9 (490.23871540000005)

Lys Ser Gln Glu

C19H34N6O9 (490.23871540000005)

Lys Thr Asp Gln

C19H34N6O9 (490.23871540000005)

Lys Thr Glu Asn

C19H34N6O9 (490.23871540000005)

Lys Thr Asn Glu

C19H34N6O9 (490.23871540000005)

Lys Thr Gln Asp

C19H34N6O9 (490.23871540000005)

Leu Asp Phe Pro

C24H34N4O7 (490.2427374)

Leu Asp Pro Phe

C24H34N4O7 (490.2427374)

Leu Glu Glu Thr

C20H34N4O10 (490.2274824)

Leu Glu Thr Glu

C20H34N4O10 (490.2274824)

Leu Phe Asp Pro

C24H34N4O7 (490.2427374)

Leu Phe Pro Asp

C24H34N4O7 (490.2427374)

Leu Met Met Pro

C21H38N4O5S2 (490.2283498)

Leu Met Pro Met

C21H38N4O5S2 (490.2283498)

Leu Pro Asp Phe

C24H34N4O7 (490.2427374)

Leu Pro Phe Asp

C24H34N4O7 (490.2427374)

Leu Pro Met Met

C21H38N4O5S2 (490.2283498)

Leu Thr Glu Glu

C20H34N4O10 (490.2274824)

Met Ala Asn Arg

C18H34N8O6S (490.23219040000004)

Met Ala Arg Asn

C18H34N8O6S (490.23219040000004)

Met Phe Pro Pro

C24H34N4O5S (490.22497940000005)

Met Gly Gln Arg

C18H34N8O6S (490.23219040000004)

Met Gly Arg Gln

C18H34N8O6S (490.23219040000004)

Met Ile Met Pro

C21H38N4O5S2 (490.2283498)

Met Ile Pro Met

C21H38N4O5S2 (490.2283498)

Met Leu Met Pro

C21H38N4O5S2 (490.2283498)

Met Leu Pro Met

C21H38N4O5S2 (490.2283498)

Met Met Ile Pro

C21H38N4O5S2 (490.2283498)

Met Met Leu Pro

C21H38N4O5S2 (490.2283498)

Met Met Pro Ile

C21H38N4O5S2 (490.2283498)

Met Met Pro Leu

C21H38N4O5S2 (490.2283498)

Met Asn Ala Arg

C18H34N8O6S (490.23219040000004)

Met Asn Arg Ala

C18H34N8O6S (490.23219040000004)

Met Pro Phe Pro

C24H34N4O5S (490.22497940000005)

Met Pro Ile Met

C21H38N4O5S2 (490.2283498)

Met Pro Leu Met

C21H38N4O5S2 (490.2283498)

Met Pro Met Ile

C21H38N4O5S2 (490.2283498)

Met Pro Met Leu

C21H38N4O5S2 (490.2283498)

Met Pro Pro Phe

C24H34N4O5S (490.22497940000005)

Met Gln Gly Arg

C18H34N8O6S (490.23219040000004)

Met Gln Asn Val

C19H34N6O7S (490.22095740000003)

Met Gln Arg Gly

C18H34N8O6S (490.23219040000004)

Met Arg Ala Asn

C18H34N8O6S (490.23219040000004)

Met Arg Gly Gln

C18H34N8O6S (490.23219040000004)

Met Arg Asn Ala

C18H34N8O6S (490.23219040000004)

Met Arg Gln Gly

C18H34N8O6S (490.23219040000004)

Met Val Asn Gln

C19H34N6O7S (490.22095740000003)

Met Val Gln Asn

C19H34N6O7S (490.22095740000003)

Asn Ala Met Arg

C18H34N8O6S (490.23219040000004)

Asn Ala Arg Met

C18H34N8O6S (490.23219040000004)

Asn Cys Arg Val

C18H34N8O6S (490.23219040000004)

Asn Cys Val Arg

C18H34N8O6S (490.23219040000004)

Asn Glu Lys Thr

C19H34N6O9 (490.23871540000005)

Asn Glu Thr Lys

C19H34N6O9 (490.23871540000005)

Asn Ile Met Asn

C19H34N6O7S (490.22095740000003)

Asn Ile Asn Met

C19H34N6O7S (490.22095740000003)

Asn Lys Glu Thr

C19H34N6O9 (490.23871540000005)

Asn Lys Thr Glu

C19H34N6O9 (490.23871540000005)

Asn Leu Asn Met

C19H34N6O7S (490.22095740000003)

Asn Met Ala Arg

C18H34N8O6S (490.23219040000004)

Asn Met Ile Asn

C19H34N6O7S (490.22095740000003)

Asn Met Leu Asn

C19H34N6O7S (490.22095740000003)

Asn Met Asn Ile

C19H34N6O7S (490.22095740000003)

Asn Met Asn Leu

C19H34N6O7S (490.22095740000003)

Asn Met Gln Val

C19H34N6O7S (490.22095740000003)

Asn Met Arg Ala

C18H34N8O6S (490.23219040000004)

Asn Met Val Gln

C19H34N6O7S (490.22095740000003)

Asn Asn Ile Met

C19H34N6O7S (490.22095740000003)

Asn Arg Ala Met

C18H34N8O6S (490.23219040000004)

Asn Arg Cys Val

C18H34N8O6S (490.23219040000004)

Asn Arg Met Ala

C18H34N8O6S (490.23219040000004)

Asn Arg Val Cys

C18H34N8O6S (490.23219040000004)

Asn Thr Lys Glu

C19H34N6O9 (490.23871540000005)

Asn Val Cys Arg

C18H34N8O6S (490.23219040000004)

Asn Val Arg Cys

C18H34N8O6S (490.23219040000004)

Pro Asp Phe Ile

C24H34N4O7 (490.2427374)

Pro Asp Phe Leu

C24H34N4O7 (490.2427374)

Pro Asp Ile Phe

C24H34N4O7 (490.2427374)

Pro Asp Leu Phe

C24H34N4O7 (490.2427374)

Pro Glu Phe Val

C24H34N4O7 (490.2427374)

Pro Glu Val Phe

C24H34N4O7 (490.2427374)

Pro Phe Asp Ile

C24H34N4O7 (490.2427374)

Pro Phe Asp Leu

C24H34N4O7 (490.2427374)

Pro Phe Glu Val

C24H34N4O7 (490.2427374)

Pro Phe Ile Asp

C24H34N4O7 (490.2427374)

Pro Phe Leu Asp

C24H34N4O7 (490.2427374)

Pro Phe Met Pro

C24H34N4O5S (490.22497940000005)

Pro Phe Pro Met

C24H34N4O5S (490.22497940000005)

Pro Phe Val Glu

C24H34N4O7 (490.2427374)

Pro His His Thr

C21H30N8O6 (490.22882)

Pro His Thr His

C21H30N8O6 (490.22882)

Pro Ile Asp Phe

C24H34N4O7 (490.2427374)

Pro Ile Phe Asp

C24H34N4O7 (490.2427374)

Pro Ile Met Met

C21H38N4O5S2 (490.2283498)

Pro Leu Asp Phe

C24H34N4O7 (490.2427374)

Pro Leu Phe Asp

C24H34N4O7 (490.2427374)

Pro Leu Met Met

C21H38N4O5S2 (490.2283498)

Pro Met Phe Pro

C24H34N4O5S (490.22497940000005)

Pro Met Ile Met

C21H38N4O5S2 (490.2283498)

Pro Met Leu Met

C21H38N4O5S2 (490.2283498)

Pro Met Met Ile

C21H38N4O5S2 (490.2283498)

Pro Met Met Leu

C21H38N4O5S2 (490.2283498)

Pro Met Pro Phe

C24H34N4O5S (490.22497940000005)

Pro Pro Phe Met

C24H34N4O5S (490.22497940000005)

Pro Pro Met Phe

C24H34N4O5S (490.22497940000005)

Pro Thr His His

C21H30N8O6 (490.22882)

Pro Val Glu Phe

C24H34N4O7 (490.2427374)

Pro Val Phe Glu

C24H34N4O7 (490.2427374)

Gln Asp Lys Thr

C19H34N6O9 (490.23871540000005)

Gln Asp Thr Lys

C19H34N6O9 (490.23871540000005)

Gln Glu Lys Ser

C19H34N6O9 (490.23871540000005)

Gln Glu Ser Lys

C19H34N6O9 (490.23871540000005)

Gln Gly Met Arg

C18H34N8O6S (490.23219040000004)

Gln Gly Arg Met

C18H34N8O6S (490.23219040000004)

Gln Lys Asp Thr

C19H34N6O9 (490.23871540000005)

Gln Lys Glu Ser

C19H34N6O9 (490.23871540000005)

Gln Lys Ser Glu

C19H34N6O9 (490.23871540000005)

Gln Lys Thr Asp

C19H34N6O9 (490.23871540000005)

Gln Met Gly Arg

C18H34N8O6S (490.23219040000004)

Gln Met Arg Gly

C18H34N8O6S (490.23219040000004)

Gln Arg Gly Met

C18H34N8O6S (490.23219040000004)

Gln Arg Met Gly

C18H34N8O6S (490.23219040000004)

Gln Ser Glu Lys

C19H34N6O9 (490.23871540000005)

Gln Ser Lys Glu

C19H34N6O9 (490.23871540000005)

Gln Thr Asp Lys

C19H34N6O9 (490.23871540000005)

Gln Thr Lys Asp

C19H34N6O9 (490.23871540000005)

Arg Ala Met Asn

C18H34N8O6S (490.23219040000004)

Arg Ala Asn Met

C18H34N8O6S (490.23219040000004)

Arg Cys Gly Arg

C17H34N10O5S (490.24342340000004)

Arg Cys Asn Val

C18H34N8O6S (490.23219040000004)

Arg Cys Arg Gly

C17H34N10O5S (490.24342340000004)

Arg Cys Val Asn

C18H34N8O6S (490.23219040000004)

Arg Gly Cys Arg

C17H34N10O5S (490.24342340000004)

Arg Gly Met Gln

C18H34N8O6S (490.23219040000004)

Arg Gly Gln Met

C18H34N8O6S (490.23219040000004)

Arg Gly Arg Cys

C17H34N10O5S (490.24342340000004)

Arg Met Ala Asn

C18H34N8O6S (490.23219040000004)

Arg Met Gly Gln

C18H34N8O6S (490.23219040000004)

Arg Met Asn Ala

C18H34N8O6S (490.23219040000004)

Arg Met Gln Gly

C18H34N8O6S (490.23219040000004)

Arg Asn Ala Met

C18H34N8O6S (490.23219040000004)

Arg Asn Cys Val

C18H34N8O6S (490.23219040000004)

Arg Asn Met Ala

C18H34N8O6S (490.23219040000004)

Arg Asn Val Cys

C18H34N8O6S (490.23219040000004)

Arg Gln Gly Met

C18H34N8O6S (490.23219040000004)

Arg Gln Met Gly

C18H34N8O6S (490.23219040000004)

Arg Arg Cys Gly

C17H34N10O5S (490.24342340000004)

Arg Arg Gly Cys

C17H34N10O5S (490.24342340000004)

Arg Val Cys Asn

C18H34N8O6S (490.23219040000004)

Arg Val Asn Cys

C18H34N8O6S (490.23219040000004)

Ser Glu Lys Gln

C19H34N6O9 (490.23871540000005)

Ser Lys Glu Gln

C19H34N6O9 (490.23871540000005)

Ser Lys Gln Glu

C19H34N6O9 (490.23871540000005)

Ser Gln Glu Lys

C19H34N6O9 (490.23871540000005)

Ser Gln Lys Glu

C19H34N6O9 (490.23871540000005)

Thr Asp Lys Gln

C19H34N6O9 (490.23871540000005)

Thr Glu Glu Ile

C20H34N4O10 (490.2274824)

Thr Glu Glu Leu

C20H34N4O10 (490.2274824)

Thr Glu Ile Glu

C20H34N4O10 (490.2274824)

Thr Glu Lys Asn

C19H34N6O9 (490.23871540000005)

Thr Glu Leu Glu

C20H34N4O10 (490.2274824)

Thr Glu Asn Lys

C19H34N6O9 (490.23871540000005)

Thr His His Pro

C21H30N8O6 (490.22882)

Thr His Pro His

C21H30N8O6 (490.22882)

Thr Ile Glu Glu

C20H34N4O10 (490.2274824)

Thr Lys Asp Gln

C19H34N6O9 (490.23871540000005)

Thr Lys Glu Asn

C19H34N6O9 (490.23871540000005)

Thr Lys Gln Asp

C19H34N6O9 (490.23871540000005)

Thr Leu Glu Glu

C20H34N4O10 (490.2274824)

Thr Asn Glu Lys

C19H34N6O9 (490.23871540000005)

Thr Pro His His

C21H30N8O6 (490.22882)

Thr Gln Asp Lys

C19H34N6O9 (490.23871540000005)

Thr Gln Lys Asp

C19H34N6O9 (490.23871540000005)

Val Cys Asn Arg

C18H34N8O6S (490.23219040000004)

Val Cys Arg Asn

C18H34N8O6S (490.23219040000004)

Val Glu Phe Pro

C24H34N4O7 (490.2427374)

Val Glu Pro Phe

C24H34N4O7 (490.2427374)

Val Phe Glu Pro

C24H34N4O7 (490.2427374)

Val Phe Pro Glu

C24H34N4O7 (490.2427374)

Val Asn Cys Arg

C18H34N8O6S (490.23219040000004)

Val Asn Arg Cys

C18H34N8O6S (490.23219040000004)

Val Pro Glu Phe

C24H34N4O7 (490.2427374)

Val Pro Phe Glu

C24H34N4O7 (490.2427374)

Val Arg Cys Asn

C18H34N8O6S (490.23219040000004)

Val Arg Asn Cys

C18H34N8O6S (490.23219040000004)

AAKSD

C19H34N6O9 (490.23871540000005)

3,5,6-tri-O-.benzyl-1,2-O-isopropylidene-alpha-D-glucofuranose

C30H34O6 (490.2355264)

Rhodamine 101 inner salt

C32H30N2O3 (490.225631)

butane-1,4-diol,hexanedioic acid,5-isocyanato-5-[(1-isocyanatocyclohexa-2,4-dien-1-yl)methyl]cyclohexa-1,3-diene

C25H34N2O8 (490.2315044)

Ivabradine metabolite N-Demethyl Ivabradine (hydrochloride)

C26H35ClN2O5 (490.22343700000005)

meta-Glimepiride Impurity

C24H34N4O5S (490.22497940000005)

N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide

C25H30N8OS (490.226317)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor

4-hydroxy-3-(1H-indol-3-yl)-5-(3-methylbut-2-enyl)-6-[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]cyclohexa-3,5-diene-1,2-dione

C32H30N2O3 (490.225631)

PA(2:0/18:2(10E,12Z)+=O(9))

C23H39O9P (490.23315740000004)

PA(18:2(10E,12Z)+=O(9)/2:0)

C23H39O9P (490.23315740000004)

PA(2:0/18:2(9Z,11E)+=O(13))

C23H39O9P (490.23315740000004)

PA(18:2(9Z,11E)+=O(13)/2:0)

C23H39O9P (490.23315740000004)

[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H39O9P (490.23315740000004)

[(2R)-2-acetyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H39O9P (490.23315740000004)

[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H39O9P (490.23315740000004)

[(2R)-2-acetyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H39O9P (490.23315740000004)

rac-(2E)-1-[5,7-dihydroxy-2-methyl-6-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)-2H-chromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one

C30H34O6 (490.2355264)

Mallotophilippen D

C30H34O6 (490.2355264)

A member of the class of chalcones that is chalcone substituted by hydroxy groups at positions 3, 4, 2 and 4, a geranyl group at position 3 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 5 and 6. Isolated from the fruits of Mallotus philippensis, it exhibits anti-inflammatory and immunoregulatory activities.

[(8R,9R,10S)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

[(8R,9S,10R)-9-[4-(3-methylphenyl)phenyl]-6-(2-methylphenyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

1-(2,5-difluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C25H32F2N4O4 (490.23914959999996)

(3S,6aR,8S,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

[(8R,9S,10R)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

1-(2,5-difluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C25H32F2N4O4 (490.23914959999996)

(3S,6aS,8R,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

(3R,6aR,8R,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

(3R,6aS,8R,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-12-(pyridine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C27H30N4O5 (490.221609)

(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-methylsulfonyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C24H34N4O5S (490.22497940000005)

(3S,6aR,8R,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

(3R,6aS,8S,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

1-(2,5-difluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C25H32F2N4O4 (490.23914959999996)

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

[(8S,9R,10S)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

2-(dimethylamino)-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pyridin-4-yl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylacetamide

C24H34N4O5S (490.22497940000005)

1-(2,5-difluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C25H32F2N4O4 (490.23914959999996)

1-(2,5-difluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C25H32F2N4O4 (490.23914959999996)

1-(2,5-difluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea

C25H32F2N4O4 (490.23914959999996)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C24H34N4O5S (490.22497940000005)

(3R,6aR,8S,10aR)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

(3S,6aS,8S,10aS)-N-(1,3-benzodioxol-5-yl)-3-hydroxy-8-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide

C24H34N4O7 (490.2427374)

(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-12-(pyridine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C27H30N4O5 (490.221609)

(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-12-methylsulfonyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C24H34N4O5S (490.22497940000005)

[(8R,9R,10R)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

[(8S,9S,10R)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

[(8S,9S,10S)-9-[4-(2-methylphenyl)phenyl]-6-(phenylmethyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

C29H34N2O3S (490.2290014)

(1S)-N-cyclopentyl-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide

C24H34N4O5S (490.22497940000005)

(R)-mallotophilippen E

C30H34O6 (490.2355264)

The (R)-enantiomer of mallotophilippen E.

(S)-mallotophilippen E

C30H34O6 (490.2355264)

The (S)-enantiomer of mallotophilippen E.

5-(2,3-Dimethoxyphenyl)-1-[2-(dimethylamino)ethyl]-4-(5-methyl-1-phenylpyrazole-4-carbonyl)pyrrolidine-2,3-dione

C27H30N4O5 (490.221609)

(RS)-mallotophilippen E

C30H34O6 (490.2355264)

A racemate composed of equimolar quantities of R- and S- mallotophilippen E. Isolated from the fruits of Mallotus philippensis, it exhibits anti-inflammatory and immunoregulatory activities.

mallotophilippen E

C30H34O6 (490.2355264)

A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 3, 4, 2 and 4, a prenyl group at position 3 and a 6-methyl-6-(4-methylpent-3-en-1-yl)-3,6-dihydro-2H-pyran ring fused across positions 5 and 6

LPA 20:4;O2

C23H39O9P (490.23315740000004)

PA 14:1/6:2;O

C23H39O9P (490.23315740000004)

PA 20:3;O

C23H39O9P (490.23315740000004)

ST 23:1;O6;S

C23H38O9S (490.2236418)

ST 27:5;O3;S

C27H38O6S (490.2388968)

5,7-dihydroxy-2-[8-hydroxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)chromen-6-yl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

13,26-dihydroxy-1,6,6,20,24-pentamethyl-7,22-dioxahexacyclo[13.12.0.0²,¹³.0⁵,¹¹.0¹⁶,²⁵.0¹⁸,²³]heptacosa-9,11,16(25),17,19,23-hexaene-8,21-dione

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-[(2s)-8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

5,7-dihydroxy-2-[8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

5,7-dihydroxy-2-[8-hydroxy-2-methyl-2-(4-methylpenta-1,3-dien-1-yl)-3,4-dihydro-1-benzopyran-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

(2r)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone

C30H34O6 (490.2355264)

{"Ingredient_id": "HBIN006516","Ingredient_name": "(2r)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone","Alias": "NA","Ingredient_formula": "C30H34O6","Ingredient_Smile": "CC(=CCC1=C(C=C(C(=C1)C2CC(=O)C3=C(C4=C(C(=C3O2)CC=C(C)C)OC(C=C4)(C)C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21701","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2s)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone

C30H34O6 (490.2355264)

{"Ingredient_id": "HBIN006751","Ingredient_name": "(2s)-5,2',4'-trihydroxy-8,5'-di(3-methylbut-2-enyl)-6,7-(3,3-dimethylpyrano)flavanone","Alias": "NA","Ingredient_formula": "C30H34O6","Ingredient_Smile": "CC(=CCC1=C(C=C(C(=C1)C2CC(=O)C3=C(C4=C(C(=C3O2)CC=C(C)C)OC(C=C4)(C)C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21702","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-{5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,4-dihydroxy-2-(3-methylbut-2-en-1-yl)phenyl}-5,7-dihydroxychromen-4-one

C30H34O6 (490.2355264)

(2r)-2-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5-hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-2h,3h-pyrano[3,2-g]chromen-4-one

C30H34O6 (490.2355264)

1-[5,7-dihydroxy-2-methyl-6-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)chromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one

C30H34O6 (490.2355264)

(1'r,2's,3ar,4's,4ar,5s,8s,8'r,9as,10'r,11's)-2',8,11'-trimethyl-3,7'-dimethylidene-3a,4,4a,8,9,9a-hexahydro-5'-oxaspiro[azuleno[6,5-b]furan-5,13'-tetracyclo[9.2.2.0¹,¹⁰.0⁴,⁸]pentadecane]-2,6,6',15'-tetrone

C30H34O6 (490.2355264)

2-[3-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxyphenyl]-3,5,7-trihydroxy-8-(3-methylbut-2-en-1-yl)chromen-4-one

C30H34O6 (490.2355264)

(2s)-4-hydroxy-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-5-(3-methylbutanoyl)-9-phenyl-2h,3h-furo[2,3-f]chromen-7-one

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-[(2r)-8-hydroxy-2-methyl-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

(1r,2s,5r,13s,15r,26r)-13,26-dihydroxy-1,6,6,20,24-pentamethyl-7,22-dioxahexacyclo[13.12.0.0²,¹³.0⁵,¹¹.0¹⁶,²⁵.0¹⁸,²³]heptacosa-9,11,16(25),17,19,23-hexaene-8,21-dione

C30H34O6 (490.2355264)

trimethidinium methosulfate

C19H42N2O8S2 (490.2382452)

(1r,2s,3r,4s,6r,7r,8r,9r,12s,13s)-9-(acetyloxy)-3-(chloromethyl)-3,12,13-trihydroxy-6-isopropyl-9,13-dimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-4-yl acetate

C24H39ClO8 (490.2333324)

4-hydroxy-2-(2-hydroxy-6-methylhept-5-en-2-yl)-5-(3-methylbutanoyl)-9-phenyl-2h,3h-furo[2,3-f]chromen-7-one

C30H34O6 (490.2355264)

5,7-dihydroxy-2-[8-hydroxy-2-methyl-2-(4-methylpenta-1,3-dien-1-yl)-3,4-dihydro-1-benzopyran-6-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

3-(3,4-dihydroxyphenyl)-1-[6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-2,2-dimethylchromen-8-yl]prop-2-en-1-one

C30H34O6 (490.2355264)

4-hydroxy-6-(1h-indol-3-yl)-5-(3-methylbut-2-en-1-yl)-3-[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]cyclohexa-3,5-diene-1,2-dione

C32H30N2O3 (490.225631)

(1r,19r)-10,14-dihydroxy-6,6,16,20,20-pentamethyl-15-(3-methylbut-2-en-1-yl)-7,21,23-trioxahexacyclo[11.8.1.1¹,¹⁹.0²,¹¹.0³,⁸.0¹⁷,²²]tricosa-2(11),4,9,13,15,17(22)-hexaen-12-one

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-[(2s)-8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

(1'r,2's,3r,3as,5's,6's,6ar,9r,9's,9ar,9bs)-3,5'-dimethyl-6,15'-dimethylidene-3,3a,4,5,6a,7,9a,9b-octahydro-3'-oxaspiro[azuleno[4,5-b]furan-9,12'-tetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadecan]-13'(16')-ene-2,4',8,14'-tetrone

C30H34O6 (490.2355264)

1-(1-methoxy-3-methylcarbazol-9-yl)-3,3,5-trimethyl-1h,2h,11h-pyrano[3,2-a]carbazol-2-ol

C32H30N2O3 (490.225631)

2-(2,4-dihydroxyphenyl)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)chromen-4-one

C30H34O6 (490.2355264)

2-(2,4-dihydroxyphenyl)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)chromen-4-one

C30H34O6 (490.2355264)

(3ar,5r,5as,9ar)-3a-[(3ar,5r,5as,9ar)-1,5,8-trimethyl-2,7-dioxo-4h,5h,5ah,6h,9ah-naphtho[2,1-b]furan-3a-yl]-1,5,8-trimethyl-4h,5h,5ah,6h,9ah-naphtho[2,1-b]furan-2,7-dione

C30H34O6 (490.2355264)

(2r,7r,9s,10r,12s)-2-hydroxy-7-[(2r,9s,10r,12s)-2-hydroxy-4,9-dimethyl-13-methylidene-5-oxo-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-7-yl]-4,9-dimethyl-13-methylidene-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-5-one

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-(7-hydroxy-2,2-dimethylchromen-6-yl)-6,8-bis(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

(1s,2r)-1-(1-methoxy-3-methylcarbazol-9-yl)-3,3,5-trimethyl-1h,2h,11h-pyrano[3,2-a]carbazol-2-ol

C32H30N2O3 (490.225631)

2-[3,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5-hydroxy-8,8-dimethyl-6-(3-methylbut-2-en-1-yl)-2h,3h-pyrano[2,3-f]chromen-4-one

C30H34O6 (490.2355264)

2',8,11'-trimethyl-3,7'-dimethylidene-3a,4,4a,8,9,9a-hexahydro-5'-oxaspiro[azuleno[6,5-b]furan-5,13'-tetracyclo[9.2.2.0¹,¹⁰.0⁴,⁸]pentadecane]-2,6,6',15'-tetrone

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-[(2s)-8-hydroxy-2-methyl-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-[(2r)-8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

3,5'-dimethyl-6,15'-dimethylidene-3,3a,4,5,6a,7,9a,9b-octahydro-3'-oxaspiro[azuleno[4,5-b]furan-9,12'-tetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadecan]-13'(16')-ene-2,4',8,14'-tetrone

C30H34O6 (490.2355264)

2-[2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4-dihydroxyphenyl]-5-hydroxy-8,8-dimethyl-2h,3h-pyrano[3,2-g]chromen-4-one

C30H34O6 (490.2355264)

(2s)-2-{2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,4-dihydroxyphenyl}-5-hydroxy-8,8-dimethyl-2h,3h-pyrano[3,2-g]chromen-4-one

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-(8-hydroxy-2,2-dimethylchromen-6-yl)-6,8-bis(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

3-[5-(3,7-dimethylocta-2,6-dien-1-yl)-3,4-dihydroxy-2-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxychromen-4-one

C30H34O6 (490.2355264)

(2s)-2-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5-hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-2h,3h-pyrano[3,2-g]chromen-4-one

C30H34O6 (490.2355264)

(2s)-5,7-dihydroxy-2-[8-hydroxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)chromen-6-yl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one

C30H34O6 (490.2355264)

4-[(21z)-5,5,11,11,17,17-hexamethyl-6,12,16,22-tetraoxapentacyclo[12.8.0.0²,⁷.0⁸,¹³.0¹⁵,²⁰]docosa-1(14),2(7),8(13),15(20)-tetraen-21-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one

C30H34O6 (490.2355264)

1,5,8-trimethyl-3a-{1,5,8-trimethyl-2,7-dioxo-4h,5h,5ah,6h,9ah-naphtho[2,1-b]furan-3a-yl}-4h,5h,5ah,6h,9ah-naphtho[2,1-b]furan-2,7-dione

C30H34O6 (490.2355264)

2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)chromen-4-one

C30H34O6 (490.2355264)

(2e)-1-[5,7-dihydroxy-2-methyl-6-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)chromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one

C30H34O6 (490.2355264)

2-hydroxy-7-{2-hydroxy-4,9-dimethyl-13-methylidene-5-oxo-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-7-yl}-4,9-dimethyl-13-methylidene-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-5-one

C30H34O6 (490.2355264)

(1s,2r,7r,9s,10r,12s)-2-hydroxy-7-[(1s,2r,7r,9s,10r,12s)-2-hydroxy-4,9-dimethyl-13-methylidene-5-oxo-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-7-yl]-4,9-dimethyl-13-methylidene-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-5-one

C30H34O6 (490.2355264)

2-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-5-hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-2h,3h-pyrano[3,2-g]chromen-4-one

C30H34O6 (490.2355264)